The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...
Cytoreductive surgery removes tumors that have spread throughout your abdominal cavity. It’s often combined with another procedure called hyperthermic intraperitoneal chemotherapy. You may need ...
Cytoreductive nephrectomy (CN ... This review summarizes current arguments for CN and how to best select patients for surgery. Ongoing trials are key in generating evidence towards a personalized ...
Hosted on MSN24d
Adding HIPEC Boosts Survival in Recurrent Ovarian CancerAdding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery significantly improved overall survival (OS) in women with platinum-sensitive, recurrent epithelial ovarian ...
The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...
The benefits of HIPEC include improved local control of cancer, reduced recurrence rates, and enhanced survival outcomes for ...
Among patients with platinum-sensitive peritoneal recurrent epithelial ovarian cancer undergoing secondary cytoreductive surgery (SCS), the addition of hyperthermic intraperitoneal chemotherapy (HIPEC ...
AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ... with traditional methods in predicting CC surgery outcomes for patients with OC.
MUSTAFA RAOOF ONCOLOGY Assistant Professor, Division of Surgical Oncology, Department of Surgery; Assistant Professor, Department of Cancer Genetics and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results